Uptake and 1-year outcomes of lung transplantation for COVID-19

Ruck, Jessica M.; Zhou, Alice L.; Florissi, Isabella; Ha, Jinny S.; Shah, Pali D.; Massie, Allan B.; Segev, Dorry L.; Merlo, Christian A.; Bush, Errol L.

doi:10.1016/j.jtcvs.2023.05.029

The Journal of Thoracic and Cardiovascular Surgery

2024

DOI: 10.1016/j.jtcvs.2023.05.029

|View full text |Cite

Uptake and 1-year outcomes of lung transplantation for COVID-19

Jessica M. Ruck

Alice L. Zhou

Isabella Florissi

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Accumulating evidence using data from individual centers, as well as national registries, substantiating the advantages of lung transplant for patients who experience irreversible lung damage due to COVID-19 infection, finds an essential supplement in the retrospective review by Tasoudis et al The study discerned that patients receiving lung transplants for COVID-19–related acute respiratory distress syndrome (ARDS) and pulmonary fibrosis in the US demonstrated comparable overall survival rates with those who exhibited other pretransplant pathologies.…”

mentioning

confidence: 99%

Lung Transplant for Acute Respiratory Distress Syndrome

Cerier

Bharat

2023

JAMA Surg

View full text Add to dashboard Cite

Accumulating evidence using data from individual centers, 1 as well as national registries, 2,3 substantiating the advantages of lung transplant for patients who experience irreversible lung damage due to COVID-19 infection, finds an essential supplement in the retrospective review by Tasoudis et al. 4 The study discerned that patients receiving lung transplants for COVID-19-related acute respiratory distress syndrome (ARDS) and pulmonary fibrosis in the US demonstrated comparable overall survival rates with those who exhibited other pretransplant pathologies.Previously, our team at Northwestern University, the Successful Clinical Response in Pneumonia Therapy (SCRIPT) study investigators, identified that SARS-CoV-2 elicits T-cell chemoattractants when infecting alveolar macrophages. 5 Recruitment of T cells initiates a positive feedback loop with the infected macrophages, provoking spatially limited alveolitis, which results in persistent alveolar inflammation. Tissue clearing of COVID-19-affected human lungs coupled with matrix imaging revealed that such inflammation can escalate to permanent structural loss marked by the emergence of KRT17-positive aberrant basaloid cells, a potential indicator of irreversible lung damage, underscoring the importance of lung transplant for certain patients who fail to recuperate. 6 The probability of sufficient lung function recovery appears to decrease over time while receiving extracorporeal support whereas the risk of death increases, 7 leading many centers, ours included, to contemplate the possibility of transplant after a minimum of 6 weeks of extracorporeal respiratory support. This consideration is particularly pertinent in cases of persistent severe ARDS and the development of medically refractory complications, antimicrobial resistant pneumonia, and

show abstract

mentioning

confidence: 99%

Lung Transplant for Acute Respiratory Distress Syndrome

Cerier

Bharat

2023

JAMA Surg

View full text Add to dashboard Cite

show abstract

Lung Transplantation in the United States for COVID-19 Related Lung Disease During the Pandemic

D’Cunha,

Jenkins,

Wilson

et al. 2024

Lung

View full text Add to dashboard Cite

Use of Extracorporeal Membrane Oxygenation for Patients with Coronavirus Disease 2019 Infection

Ruck,

Bush

2024

Advances in Surgery

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Uptake and 1-year outcomes of lung transplantation for COVID-19

Cited by 3 publications

References 15 publications

Lung Transplant for Acute Respiratory Distress Syndrome

Lung Transplant for Acute Respiratory Distress Syndrome

Lung Transplantation in the United States for COVID-19 Related Lung Disease During the Pandemic

Use of Extracorporeal Membrane Oxygenation for Patients with Coronavirus Disease 2019 Infection

Contact Info

Product

Resources

About